BYLUTA 50 TABLET

MRP
432.5/Strip

Description
Each film-coated tablet contains Bicalutamide IP 50 mg

Doses
As Directed by physician

Indication
Bicalutamide is used together with a luteinizing hormone-releasing hormone (LHRH) analog (e.g., goserelin or leuprolide) to treat stage D2 metastatic prostate cancer (cancer that has spread) in men. Bicalutamide belongs to the group of medicines called antiandrogens.